Objectives: Influenza (flu) vaccination has been associated with a reduction in cardiovascular mortality in a metropolitan area of Brazil. Nevertheless, it is unknown whether sex influences this outcome. The aim of the study was analyze the cardiovascular disease (CVD) mortality in women and men before and after the initiation of a flu vaccination program. Methods: We analyzed the mortality of ischemic heart disease (IHD), stroke, and external causes (EC) in women and men at least 60 years of age in the metropolitan area of São Paulo before and after the initiation of a flu vaccination program. Estimates of the population were obtained from the Brazilian Institute of Geography and Statistics and the mortality data from the Ministry of Health for the period between 1980 and 2006. The risk of death was adjusted by the direct method using the 1960 world standard population. Results: Change in trend in mortality after vaccination was significant only for IHD (-9.3% vs -30.2%; P = .022) and remained unchanged for stroke (-31.4% vs -25.3%; P =.931) and EC (-8.5% vs -1.2%; P = .941). The decline in IHD pre-(1980IHD pre-( -1995 and post-vaccination (1996-2006) was greater in women (-3.8% vs -28.8%; P = .001) than in men (-12.9% vs -30.4%; P = .054). Conclusion: Flu vaccination was associated with a significant reduction of IHD mortality, more so in women than in men.
Introduction
Cardiovascular disease (CVD) is the main cause of death in Brazilian women and men. In both groups, a decreasing tendency in CVD mortality has been observed. 1 The causes for this outcome are not completely known but may involve some degree of control of the main risk factors for CVD. Nevertheless, other interventions-one of which is influenza (flu) vaccination-may be influencing reductions in CVD morbidity and mortality. It is well known that patients with ischemic heart disease (IHD) are at greater risk of cardiovascular complications during influenza infections. 2, 3 Also, previous studies show improvement in CVD prognosis with influenza vaccination. 4, 5 Since 2006, the American Heart Association and the American College of Cardiology guidelines have recommended vaccination against the flu virus in patients with atherosclerotic disease. 6 The European Society of Cardiology and the Brazilian Society of Cardiology do not recommend vaccination for patients with IHD. 7, 8 In a previous ecological study, we observed an association between reduction in IHD mortality and vaccination for the flu virus, but participation by sex is unknown. 9 In the metropolitan region of São Paulo, Brazil, in 2006, 58.9% of the population ≥60 years old were women. The sex ratio was 70.7 men for 100 women. 10 Population-based studies also show a higher prevalence of women. [11] [12] [13] This study aimed to further analyze the influence of vaccination for the flu virus on CVD mortality in the city of São Paulo, Brazil, in women and men ≥60 years of age.
Materials and Methods
This study analyzed IHD mortality, stroke, and EC rates in women and men ≥60 years of age in the metropolitan area of São Paulo before and after vaccination for the flu. Estimates of the population and mortality data for IHD, stroke, and EC were respectively obtained from the Brazilian Institute of Geography and Statistics (IBGE; http:// www.ibge.gov.br) and the Ministry of Health (http://www .datasus.gov.br). The risk of death was adjusted by the direct method using the 1960 standard world population. Mortality data per 100 000 inhabitants and percentage variations were analyzed for the pre-vaccine period, between 1980 and 1995, and after the initiation of the vaccination program, between 1996 and 2006. The EC group was used as the control group to reduce bias in studies of preventive interventions because the influence of flu vaccination on mortality by EC is virtually zero. We used the method of simple linear regression to analyze the mortality coefficients of the pre-and post-vaccination periods and the method of comparison between the slopes of the lines of simple linear regressions between periods. The software used was the Primer of Biostatistics, version 4.02 14 .
Results
Overall, the change in the mortality trend after vaccination started was significant only for IHD (-9.3% vs -30.2%; P = .022) and remained unchanged for stroke (-31.4 vs -25.3; P = .931) and EC (-8.5 vs -1.2; P = .941). In women, the prevaccine period, from 1980 to 1995, showed a mild and nonsignificant reduction in IHD mortality (-3.8%) and EC (-6.6%), but a significant reduction in mortality from stroke (-32.7%; P < .001). Simple linear regression analysis showed a nonsignificant increasing trend, with an initial adjusted average coefficient for IHD of 364.91 ± 0.57 (P = .470) and for EC of 71.3 ± 0.67 (P = .857) deaths per 100 000 inhabitants per year, and a decreasing trend, with the initial adjusted average coefficient for stroke of 571.33 ± 12.63 (p < .001) deaths per 100 000 inhabitants per year. The post-vaccine period, from 1996 to 2006, showed a significant reduction in IHD mortality (-28.8%; P < .001) and stroke (-24.9%; P < .001), with an increase in mortality from EC (18.4%; P = .004). Simple linear regression analysis showed a significant reduction, with the initial adjusted average coefficient for IHD of 399.57 ± 12.83 (p < .001) and for stroke of 412.37 ± 12.04 (p < .001) deaths per 100 000 inhabitants per year, and a nonsignificant increasing trend, with the initial adjusted average coefficient for EC of 58.75 ± 0.67 (P = .238) deaths per 100 000 inhabitants per year (Table 1) . Comparisons among the inclinations of the regression lines were similar for stroke (P = .951) and EC (P = .789); however, for IHD (P = .011), a significant reduction in the post-vaccine period was observed when compared with the pre-vaccine period (Figure 1 ). In men, the pre-vaccine period, from 1980 to 1995, showed a significant reduction in IHD mortality (-12.9%; p < .001) and stroke (-29.6%; P < .001), but a nonsignificant reduction in EC mortality (-9.2%; P = .243). Simple linear regression analysis showed a significant decreasing trend, with the initial adjusted average coefficient for IHD of 729.47 ± 4.19 (P = .009) and for stroke of 745.82 ± 14.09 (p < .001) deaths per 100 000 inhabitants per year, and a nonsignificant decreasing trend with the initial adjusted average coefficient for EC of 194.38 ± 0.73 (P = .243) deaths per 100 000 inhabitants per year. The post-vaccine period, from 1996 to 2006, showed a significant reduction in IHD mortality (-30.4) and stroke (-24.9%), with a nonsignificant reduction in EC mortality (-10.2%). Simple linear regression analysis showed a significant reduction, with the initial adjusted average coefficient for IHD of 714.96 ± 23.75 (p < .001) and for stroke of 604.33 ± 17.83 (p < .001) deaths per 100 000 inhabitants per year, and a nonsignificant decreasing trend, with the initial adjusted average coefficient for EC of 172.71 ± 1.96 (P = .168) deaths per 100 000 inhabitants per year. The comparisons among the inclinations of regression lines were similar for stroke (P = .760) and EC (P = .794); however, for IHD (P = .054), a nearly significant reduction in the post-vaccine period was observed when compared with the pre-vaccine period (Figure 1 ).
Discussion
Our study shows that flu vaccination had a greater association with a reduction in IHD deaths in women than in men.
No association was seen for stroke and EC deaths. The explanation for these results is not known. Previous studies show a reduction in IHD deaths after flu vaccination, but participation by sex is not specified. [15] [16] [17] Flu vaccination rates among elderly individuals in Europe ranged from 1.8% to 82.1% in 2008. 18 Müller and Szucs analyzed vaccination coverage of 3 consecutive influenza seasons in 5 European countries: United Kingdom, France, Italy, Germany, and Spain. 19 They showed that the vaccination coverage rate for the group aged ≥65 years was 61. 2004-2005 season. In the United States, vaccination coverage among elderly individuals was approximately 70% in 2005. 20 In Brazil, since 2000, adherence has been stable, and over 70% of individuals aged ≥60 were vaccinated. 21 Based on the above statements, a hypothesis could be made to explain why women had a better response to flu vaccination. First, a higher prevalence of women ≥60 years old is probably associated with higher vaccination rates in this group. Second, women live longer than men. Therefore, women are more likely to be revaccinated and consequently have a better prognosis. 11 Third, greater protection from the flu by the vaccine may occur in women because, in our population, the atherosclerotic process is less intense in women compared with that in men. 22 The worse atherosclerotic profile observed in men may be associated with higher susceptibility to coronary events caused by hemodynamic consequences of fever and dehydration. 23 The thrombogenic process can be intensified by the immunoinflammatory processes associated with viral infection and, occasionally, with posterior bacterial infections. 24 An ecological study such as this one has some limitations that make cause and effect questionable. In conclusion, vaccination for flu virus was associated with decreasing IHD deaths, more so in women than in men.
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